Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

TVTX holding history

Travere Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TVTX overviewAll 13F holders of TVTXFull Q2 2026 holdings

Shares (Q2 2026)
1,440,469
Value
$81.8M
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of TVTX by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,440,469$81.8M0.1%+603,925+72.2%AddedHolders
Q1 2026836,544$24.9M<0.1%−258,012−23.6%ReducedHolders
Q4 20251,094,556$41.8M<0.1%+431,304+65.0%AddedHolders
Q3 2025663,252$15.9M<0.1%−467,498−41.3%ReducedHolders
Q2 20251,130,750$16.7M<0.1%−582,842−34.0%ReducedHolders
Q1 20251,713,592$30.7M<0.1%−564,783−24.8%ReducedHolders
Q4 20242,278,375$39.7M<0.1%+438,306+23.8%AddedHolders
Q3 20241,840,069$25.7M<0.1%+306,997+20.0%AddedHolders
Q2 20241,533,072$12.6M<0.1%−311,591−16.9%ReducedHolders
Q1 20241,844,663$14.2M<0.1%+186,516+11.2%AddedHolders
Q4 20231,658,147$14.9M<0.1%+674,602+68.6%AddedHolders
Q3 2023983,545$8.79M<0.1%−277,459−22.0%ReducedHolders
Q2 20231,261,004$19.4M<0.1%+261,513+26.2%AddedHolders
Q1 2023999,491$22.5M<0.1%+532,651+114.1%AddedHolders
Q4 2022466,840$9.82M<0.1%+90,997+24.2%AddedHolders
Q3 2022375,843$9.26M<0.1%−52,984−12.4%ReducedHolders
Q2 2022428,827$10.4M<0.1%−46,574−9.8%ReducedHolders
Q1 2022475,401$12.3M<0.1%+128,060+36.9%AddedHolders
Q4 2021347,341$10.8M<0.1%−58,496−14.4%ReducedHolders
Q3 2021405,837$9.84M<0.1%−791,961−66.1%ReducedHolders
Q2 20211,197,798$17.5M<0.1%−278,681−18.9%ReducedHolders
Q1 20211,476,479$36.9M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.